Loading...
Bilateral Trade Intelligence · $38.7K Total Trade · 3 Foreign Suppliers · 4 Indian Buyers · DGFT Verified · Updated March 2026
India imported $38.7K worth of pharmaceutical formulations from Norway across 8 verified shipments, from 3 foreign suppliers to 4 Indian buyers. The top suppliers are ABACUS MEDICINE PHARMA SERVICES LTD ($35.3K) and E-PHARM LIMITED ($2.8K). The leading products are Trastuzumab ($35K) and Sodium ($2K). Average shipment value: $4.8K.
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Trastuzumab | $35.3K | 91.3% |
| 2 | Sodium | $2.3K | 5.9% |
| 3 | Nivolumab | $590 | 1.5% |
| 4 | Loratadine | $499 | 1.3% |
India imports 4+ pharmaceutical formulations from Norway with a combined trade value of $38.7K. Key products include Trastuzumab ($35K), Sodium ($2K), Nivolumab ($590), Loratadine ($499). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 8 verified Indian Customs (DGFT) shipment records.
These are the top pharmaceutical products exported from India to Norway, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Norway buyers, regulatory requirements, and logistics for that specific product corridor. Products include Trastuzumab ($35K), Sodium ($2K), Nivolumab ($590), Loratadine ($499) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
3 Indian pharmaceutical companies export finished formulations to Norway. Leading exporters include Abacus Medicine Pharma Services Ltd, E-pharm Limited, Abacus Medicine Pharma Services Limited, . The top exporter accounts for 91.3% of total India–Norway pharma exports. Source: Indian Customs (DGFT).
India exported pharmaceuticals worth $38.7K to Norway across 8 verified shipments.
1. ABACUS MEDICINE PHARMA SERVICES LTD — $35.3K. 2. E-PHARM LIMITED — $2.8K. 3. ABACUS MEDICINE PHARMA SERVICES LIMITED — $590. Total: 3 suppliers.
1. INTAS PHARMACEUTICALS LIMITED — $35.3K. 2. ACULIFE HEALTHCARE PRIVATE LIMITED — $2.3K. 3. RELIANCE LIFE SCIENCES PRIVATE LIMITED — $590. 4 buyers total.
1. Trastuzumab ($35.3K, 91.3%); 2. Sodium ($2.3K, 5.9%); 3. Nivolumab ($590, 1.5%); 4. Loratadine ($499, 1.3%)
Export: . Import: .
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $38.7K corridor reflects quality compliance and pricing advantages.
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
4 companies in Norway import pharmaceutical formulations from India. Top buyers include Intas Pharmaceuticals Limited, Aculife Healthcare Private Limited, Reliance Life Sciences Private Limited, Unison Pharmaceuticals Private Limited. The largest buyer accounts for 91.3% of India–Norway pharma imports. Source: Indian Customs (DGFT).
$4.8K per consignment across 8 shipments.
3 Indian companies. Largest: ABACUS MEDICINE PHARMA SERVICES LTD with $35.3K.
TransData Nexus covers 3 active exporters with shipment history and trade values at transdatanexus.com.
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 8 shipments.
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Exporters
4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists